The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse.
暂无分享,去创建一个
Hans Clevers | Eduard Batlle | Elena Sancho | David Rossell | Ramón Mangues | P. Jung | H. Clevers | R. Mangues | D. Rossell | E. Batlle | E. Sancho | Peter Jung | María Virtudes Céspedes | M. Iglesias | Marta Sevillano | Xavier Hernando-Momblona | Mar Iglesias | M. V. Céspedes | Anna Merlos-Suárez | Xavier Hernando-Momblona | Marta Sevillano | Francisco M Barriga | P. Muñoz | Victoria da Silva-Diz | Purificación Muñoz | Francisco M. Barriga | V. da Silva-Diz | A. Merlos-Suárez | Victoria da Silva-Diz | Victoria da Silva-Diz
[1] Jiafu Ji,et al. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours. , 2006, Carcinogenesis.
[2] N. Zeps,et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] R. Knuechel,et al. Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[4] E. Giovannucci,et al. Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer , 2008, Clinical Cancer Research.
[5] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[6] James J. Chen,et al. Kernel estimation for adjusted p , 2007, Comput. Stat. Data Anal..
[7] K. Sugihara,et al. Cyclooxygenase-2 Expression , 2004, Clinical Cancer Research.
[8] T. Pawson,et al. EphB receptor activity suppresses colorectal cancer progression , 2005, Nature.
[9] G. Smyth,et al. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.
[10] G. Stassi,et al. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. , 2010, Cancer research.
[11] G. Glinsky,et al. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. , 2005, The Journal of clinical investigation.
[12] Stuart H. Orkin,et al. A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs , 2010, Cell.
[13] L. Terracciano,et al. High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patients , 2010, International journal of cancer.
[14] Michael F. Clarke,et al. Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.
[15] L. Ricci-Vitiani,et al. Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.
[16] Paul Polakis,et al. EphB2 as a Therapeutic Antibody Drug Target for the Treatment of Colorectal Cancer , 2004, Cancer Research.
[17] A. Regev,et al. An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.
[18] Hans Clevers,et al. Transcription Factor Achaete Scute-Like 2 Controls Intestinal Stem Cell Fate , 2009, Cell.
[19] H. Clevers,et al. The Intestinal Wnt/TCF Signature. , 2007, Gastroenterology.
[20] K. Chayama,et al. Clinical Significance of Angiogenic Factor Expression at the Deepest Invasive Site of Advanced Colorectal Carcinoma , 2002, Oncology.
[21] P. Galle,et al. Effect of Chemokine Receptors CXCR4 and CCR7 on the Metastatic Behavior of Human Colorectal Cancer , 2005, Clinical Cancer Research.
[22] Tony Pawson,et al. β-Catenin and TCF Mediate Cell Positioning in the Intestinal Epithelium by Controlling the Expression of EphB/EphrinB , 2002, Cell.
[23] Louis Vermeulen,et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.
[24] J. Gordon,et al. Examining the Role of Paneth Cells in the Small Intestine by Lineage Ablation in Transgenic Mice* , 1997, The Journal of Biological Chemistry.
[25] Hans Clevers,et al. Lgr5(+ve) stem cells drive self-renewal in the stomach and build long-lived gastric units in vitro. , 2010, Cell stem cell.
[26] Suet Yi Leung,et al. Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors , 2007, Proceedings of the National Academy of Sciences.
[27] H. Clevers,et al. Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.
[28] J. Lloreta,et al. EphB–ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells , 2007, Nature Genetics.
[29] E. Verwiel,et al. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis. , 2008, Cancer research.
[30] Ian A. White,et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. , 2008, The Journal of clinical investigation.
[31] M. Todaro,et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity , 2008, Proceedings of the National Academy of Sciences.
[32] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[33] A. Reeve,et al. Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer , 2008, British Journal of Cancer.
[34] Y. Benjamini,et al. THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .
[35] H. Clevers,et al. Prominin-1/CD133 marks stem cells and early progenitors in mouse small intestine. , 2009, Gastroenterology.
[36] Hans Clevers,et al. Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.
[37] Y. Collan,et al. VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival. , 2008, Anticancer research.
[38] H. Grabsch,et al. EphB2 is a Prognostic Factor in Colorectal Cancer , 2005, Clinical Cancer Research.
[39] H. Clevers,et al. Single Lgr5 stem cells build cryptvillus structures in vitro without a mesenchymal niche , 2009, Nature.
[40] Hiroya Takeuchi,et al. Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] P. Pelicci,et al. Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content , 2010, Cell.
[42] T. Yeatman,et al. Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer. , 2010, Gastroenterology.
[43] T. Ørntoft,et al. Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer , 2009, Clinical Cancer Research.